NCT07357441
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
- Locations
-
- Novartis East Hanover, New Jersey, United States
Clinical trial condition
Myelofibrosis
Explore clinical trials studying Myelofibrosis. Study availability and eligibility vary by location and protocol.
173 public trials
47 recruiting studies
Myelofibrosis trial results
NCT00255346
- Conditions
- Acute Myeloid Leukemia, Agnogenic Myeloid Metaplasia, Bone Marrow Diseases, +29 more
- Locations
-
- The University of Texas M.D. Anderson Cancer Center Houston, Texas, United States
NCT06024915
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
- Locations
-
- Shandong Provincial Hospital Jinan, Shandong, China
NCT01760655
- Conditions
- Acute Myeloid Leukemia With FLT3/ITD Mutation, Acute Myeloid Leukemia With Gene Mutations, Acute Myeloid Leukemia With Inv(3) (q21.3;q26.2); GATA2, MECOM, +61 more
- Locations
-
- Thomas Jefferson University Philadelphia, Pennsylvania, United States
- Conditions
- Blood Platelet Disorders, Bone Marrow Diseases, Bone Marrow Neoplasms, +11 more
- Locations
-
- Tulane University New Orleans, Louisiana, United States
- Rcca Md, Llc Bethesda, Maryland, United States
- Midamerica Cancer Care Kansas City, Missouri, United States
- New Jersey Hematology Oncology Associates Llc Brick, New Jersey, United States
NCT02784496
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +4 more
- Locations
-
- Local Institution - 103 Darlinghurst, New South Wales, Australia
- Local Institution - 101 Adelaide, South Australia, Australia
- Local Institution - 105 Box Hill, Victoria, Australia
- Local Institution - 102 Langwarrin, Victoria, Australia
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
- Locations
-
- Comprehensive Cancer Center (UAB CCC) Birmingham, Alabama, United States
- Novant Health Cancer Institute Winston-Salem, North Carolina, United States
- The University of Texas MD Anderson Cancer Center Houston, Texas, United States
- Liverpool Hospital Liverpool, New South Wales, Australia
Completed
To Evaluate the Pharmacokinetics and Safety of TQ05105 Tablet in Renal Impairment Subjects
NCT06598956
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
- Locations
-
- The First Affiliated Hospital of Shandong First Medical University (Qianfoshan Hospital) Jinan, Shandong, China
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
- Locations
-
- Winter Park, Florida, United States
- Baltimore, Maryland, United States
- Houston, Texas, United States
- Vienna, Austria